...
首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
【24h】

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma

机译:miRNA信号在肝细胞癌患者中的诊断和治疗潜力

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MicroRNAs (miRNAs) are evolutionary conserved small non-coding RNAs that regulate gene expression by mediating post-transcriptional silencing of target genes. Since miRNAs are involved in fine-tuning of physiological responses, they have become of interest for diagnosis and therapy of a number of diseases. Moreover, the role of dysregulated miRNAs in maintaining the malignant phenotype has profound implications for cancer therapy. We will review the best defined cellular miRNAs and changes in their expression profile in hepatocellular carcinoma (HCC). Cellular miRNAs can also be released into the circulation, and these miRNAs are detected in most body fluids. Circulating miRNAs are associated with HCC and are possible biomarkers. Finally, by affecting several clinically relevant targets, artificially increasing or decreasing the expression level of a given miRNA offers fascinating therapeutic perspectives. We will therefore highlight recent developments in miRNA-based gene therapy with a focus on their therapeutic potential for HCC.
机译:MicroRNA(miRNA)是进化保守的小型非编码RNA,可通过介导靶基因的转录后沉默来调节基因表达。由于miRNA参与了生理反应的微调,因此它们已成为许多疾病的诊断和治疗的关注点。此外,失调的miRNA在维持恶性表型中的作用对癌症治疗具有深远的意义。我们将审查定义最明确的细胞miRNA及其在肝细胞癌(HCC)中的表达谱变化。细胞miRNA也可以释放到循环中,并且这些miRNA在大多数体液中都可以检测到。循环miRNA与肝癌相关,可能是生物标志物。最后,通过影响几个临床相关靶标,人为地增加或降低给定miRNA的表达水平提供了令人着迷的治疗前景。因此,我们将重点介绍基于miRNA的基因治疗的最新进展,重点是其对HCC的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号